Skip to content

EXEL

Exelixis, Inc.

NASDAQ · USHealthcareBiotechnology
$55.53-0.70%

Price as of Jul 20, 2026

EXEL capital

Exelixis, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.09x
Net debt / equity
-0.03x
Debt / assets
0.07x
Debt / EBITDA
0.17x
Net debt / EBITDA
-0.06x

Liquidity & coverage

Current ratio
3.26x
Quick ratio
3.19x
Cash ratio
2.10x
Interest coverage
EBITDA / interest
Working capital
$837.7M

Cash & dividend

FCF / debt
5.41x
Cash flow / debt
5.45x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.